Related Experiment Video
Updated: Jun 6, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Pathogenic and immunogenic responses in turkeys following in ovo exposure to avian metapneumovirus subtype C
Ra Mi Cha1, Mahesh Khatri, Manohar Mutnal
1Department of Veterinary and Biomedical Sciences, University of Minnesota, 1971 Commonwealth Ave., St. Paul, MN 55108, USA.
Abstract:
Commercial turkey eggs, free of antibodies to avian metapneumovirus subtype C (aMPV/C), were inoculated with aMPV/C at embryonation day (ED) 24. There was no detectable effect of virus inoculation on the hatchability of eggs. At 4 days post inoculation (DPI) (the day of hatch (ED 28)) and 9 DPI (5 days after hatch), virus replication was detected by quantitative RT-PCR in the turbinate, trachea and lung but not in the thymus or spleen. Mild histological lesions characterized by lymphoid cell infiltration were evident in the turbinate mucosa. Virus exposure inhibited the mitogenic response of splenocytes and thymocytes and upregulated gene expression of IFN-γ and IL-10 in the turbinate tissue. Turkeys hatching from virus-exposed eggs had aMPV/C-specific IgG in the serum and the lachrymal fluid. At 3 week of age, in ovo immunized turkeys were protected against a challenge with pathogenic aMPV/C.
Insights
In ovo inoculation of avian metapneumovirus subtype C (aMPV/C) into turkey eggs did not affect hatchability but induced immune responses and protection against later challenge. This study highlights the potential of in ovo immunization for controlling aMPV/C in turkeys.
Area of Science:
- Veterinary Virology
- Immunology
- Poultry Science
Background:
- Avian metapneumovirus subtype C (aMPV/C) poses a significant threat to poultry health.
- Effective control strategies for aMPV/C infections in commercial turkeys are crucial.
Purpose of the Study:
- To investigate the effects of in ovo inoculation of aMPV/C on turkey embryos and subsequent immune responses.
- To evaluate the protective efficacy of in ovo immunization against aMPV/C challenge.
Main Methods:
- Commercial turkey eggs were inoculated with aMPV/C at embryonation day 24.
- Virus replication was quantified using RT-PCR.
- Histological lesions and immune cell responses (mitogenic response, cytokine gene expression) were assessed.
- Humoral immunity (IgG) and protection against challenge were evaluated.
Main Results:
- In ovo inoculation did not impact egg hatchability.
- aMPV/C replicated in respiratory tissues (turbinate, trachea, lung) post-hatch.
- Mild lymphoid infiltration was observed in the turbinate mucosa.
- aMPV/C exposure modulated splenocyte and thymocyte responses and upregulated IFN-γ and IL-10 in turbinate tissue.
- aMPV/C-specific IgG was detected in serum and lachrymal fluid.
- In ovo immunized turkeys showed protection against a pathogenic aMPV/C challenge at 3 weeks of age.
Conclusions:
- In ovo inoculation of aMPV/C is safe regarding hatchability and induces a protective immune response in turkeys.
- This approach offers a promising strategy for early-stage protection against aMPV/C in commercial poultry.
- Further research into optimizing in ovo immunization protocols is warranted.
Related Concept Videos
Cytomegalovirus Disease
Poliomyelitis
Vaccinations
Chickenpox

